The Role of Telehealth in Pediatric and Adult Infections: Best Practices and Care Considerations for Influenza – Live Interactive Webinar

/ Print /
| ShareMore
/ Text Size +
4/15/21 7:00 pm EST
Virtual Webinar
United States


This webinar is jointly provided by Postgraduate Institute for Medicine and Spire Learning.

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Webinar Overview:

Upon completion of this activity, learners should be better able to:

  • SUMMARIZE best practices to conduct visits and assess for influenza via telehealth in the primary care setting
  • RECOMMEND influenza prevention strategies
  • IMPLEMENT proper antiviral treatment of influenza for children and adults, including patients at high risk of complications from influenza

Target Audience

This activity has been designed to meet the educational needs of physicians, nurse practitioners, physician assistants, and other members of the health care team who care for patients with influenza in the primary care setting.

Date and Time:

This webinar will be held on:

  • Thursday, April 15, 2021      7:00 - 8:15 PM EDT
  • Thursday, April 29, 2021      9:00 - 10:15 PM EDT
  • Thursday, May 13, 2021      7:00 - 8:15 PM EDT


Paul G. Auwaerter, MD, MBA, FIDSA
Clinical Director, Division of Infectious Diseases
Sherrilyn and Ken Fisher Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

Javeed Siddiqui, MD, MPH
Infectious Diseases Chief Medical Officer
Roseville, CA


  • Physicians – maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses – maximum of 1.0 contact hours of continuing nursing education
  • All other health care professionals completing this course will be issued a statement of participation.

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Spire Learning. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.

Credit Designation

  • Physician Credit Designation Statement
    The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Nursing Credit Designation Statement
    The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 contact hours of continuing nursing education.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact the CME providers, PIM and Spire Learning, for privacy policy statement information at: and